Risk-adapted Adjuvant Chemotherapy Guided by the Tumour Stage for Operated Pancreatic Adenocarcinoma Following Neoadjuvant Chemotherapy With mFOLFIRINOX
Clinical trial NCT07044453 · RECRUITING
Trial details
- NCT number
- NCT07044453
- Sponsor
- University Hospital, Rouen
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-08
- Primary completion
- 2030-09-01
- Enrollment
- 390
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.